US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVO Fertility, Inc

0.8425

-0.0097-1.14%

Post-market: 0.84250.00000.00%16:10 EST

Volume:136.68K

Turnover:114.24K

Market Cap:2.01M

PE:0.00

High:0.8893

Open:0.8600

Low:0.8010

Close:0.8522

52wk High:244.80

52wk Low:0.7101

Shares:2.39M

Float Shares:2.38M

Volume Ratio:0.50

T/O Rate:5.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-644.6282

EPS(LYR):-724.6732

ROE:--

ROA:-48.36%

PB:-0.66

PE(LYR):0.00

Loading ...

Overview Company News Filings

Beta Drugs to Acquire Majority Stake in IVF-Focused Nivian Lifesciences

INVO Fertility Appoints Terah Krigsvold as CFO and Andrea Goren as Chief Business Officer

Jin Xin Reproductive (01951) Reports IVF Egg Retrieval Cycle Decline Narrows to -1.4% in 2025

BRIEF-Terah Krigsvold Appointed As INVO's New CFO

INVO Fertility Inc - Terah Krigsvold Appointed as INVO's New CFO

THOMSON REUTERS

INVO Fertility Appoints Terah Krigsvold as CFO and Andrea Goren as Chief Business Officer

Press Release: INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy

Monash IVF Group Says Consortium Withdraws Takeover Proposal

MT Newswires Live

INVO Fertility Signs Definitive Agreement to Acquire Family Beginnings Clinic

INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”

THOMSON REUTERS

Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth

INVO Fertility Inc. Announces Date for Upcoming Special Meeting of Stockholders

Director Matthew K. Szot Reports Disposal of Invo Fertility Inc. Common Shares

Bid Target Monash IVF's Stock Trades Near Fair Value -- Market Talk

INVO Fertility Enacts 1-for-8 Reverse Stock Split

BRIEF-Invo Fertility Announces Pricing Of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS

Top Premarket Gainers

MT Newswires Live

INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”

INVO Fertility Inc trading halted, news pending

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IVF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVF\",,,,,undefined,":{"symbol":"IVF","market":"US","secType":"STK","nameCN":"INVO Fertility, Inc","latestPrice":0.8425,"timestamp":1768251600000,"preClose":0.8522,"halted":0,"volume":136683,"hourTrading":{"tag":"盘后","latestPrice":0.8425,"preClose":0.8425,"latestTime":"16:10 EST","volume":151,"amount":127.2175,"timestamp":1768252204199},"delay":0,"floatShares":2384500,"shares":2386800,"eps":-644.6282,"marketStatus":"Post-Mkt","change":-0.0097,"latestTime":"01-12 16:14:31 EST","open":0.86,"high":0.8893,"low":0.801,"amount":114237.2457792,"amplitude":0.103614,"askPrice":0.91,"askSize":200,"bidPrice":0.82,"bidSize":125,"shortable":3,"etf":0,"ttmEps":-644.6282,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1768266000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.8522,"preHourTrading":{"tag":"盘前","latestPrice":0.86,"preClose":0.8522,"latestTime":"08:20 EST","volume":3129,"amount":2692.76405055,"timestamp":1768224001076},"postHourTrading":{"tag":"盘后","latestPrice":0.8425,"preClose":0.8425,"latestTime":"16:10 EST","volume":151,"amount":127.2175,"timestamp":1768252204199},"volumeRatio":0.503458},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVF\",,,,,undefined,":{"symbol":"IVF","floatShares":2384500,"roa":"-48.36%","roe":"--","lyrEps":-724.673224,"volumeRatio":0.503458,"shares":2386800,"dividePrice":0,"high":0.8893,"amplitude":0.103614,"preClose":0.8522,"low":0.801,"week52Low":0.7101,"pbRate":"-0.66","psRate":"0.29","week52High":244.8,"institutionHeld":0,"latestPrice":0.8425,"committee":-0.230769,"eps":-644.6282,"divideRate":0,"volume":136683,"delay":0,"ttmEps":-644.6282,"open":0.86,"prevYearClose":0.7526,"prevWeekClose":0.8522,"prevMonthClose":0.7526,"prevQuarterClose":0.7526,"fiveDayClose":1.01,"twentyDayClose":1.43,"sixtyDayClose":6.032},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-28","symbol":"IVF","defaultRemindTime":1764340200000,"type":"split","dateTimestamp":1764306000000,"forFactor":8,"toFactor":1,"ratio":8},{"market":"US","date":"2025-11-17","symbol":"IVF","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763355600000,"reportTimeType":"pre","actualEps":-0.77},{"market":"US","date":"2025-08-14","symbol":"IVF","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-7.95},{"market":"US","date":"2025-07-21","symbol":"IVF","defaultRemindTime":1753104600000,"type":"split","dateTimestamp":1753070400000,"forFactor":3,"toFactor":1,"ratio":3},{"market":"US","date":"2025-05-20","symbol":"IVF","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747713600000,"reportTimeType":"post","actualEps":-12.53}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IVF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IVF\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IVF","date":"2026-01-09","current":-0.001307,"percent":0.761364,"low":-0.22016,"twenty":-0.137045,"median":-0.098089,"eighty":-0.07275,"high":-0.047608,"avg":-0.105398,"sd":0.034388,"marketCap":2152439},"quantilePoints":[{"date":"2025-05-02","current":-0.084268,"twenty":-0.093412,"median":-0.081803,"eighty":-0.076469,"marketCap":1252187},{"date":"2025-05-09","current":-0.096819,"twenty":-0.099867,"median":-0.085165,"eighty":-0.080144,"marketCap":1438683},{"date":"2025-05-16","current":-0.087854,"twenty":-0.096012,"median":-0.089646,"eighty":-0.082834,"marketCap":1305471},{"date":"2025-05-23","current":-0.047608,"twenty":-0.105515,"median":-0.090543,"eighty":-0.080144,"marketCap":1185581},{"date":"2025-05-30","current":-0.146711,"twenty":-0.145427,"median":-0.093681,"eighty":-0.082116,"marketCap":3653522},{"date":"2025-06-06","current":-0.128588,"twenty":-0.145427,"median":-0.100629,"eighty":-0.084627,"marketCap":3202205},{"date":"2025-06-13","current":-0.123231,"twenty":-0.143949,"median":-0.123231,"eighty":-0.086241,"marketCap":3068806},{"date":"2025-06-20","current":-0.109346,"twenty":-0.141878,"median":-0.113685,"eighty":-0.088033,"marketCap":2723025},{"date":"2025-06-27","current":-0.090254,"twenty":-0.139289,"median":-0.107803,"eighty":-0.087987,"marketCap":2247576},{"date":"2025-07-03","current":-0.07498,"twenty":-0.137218,"median":-0.105156,"eighty":-0.084268,"marketCap":1867217},{"date":"2025-07-11","current":-0.071161,"twenty":-0.136355,"median":-0.095474,"eighty":-0.07636,"marketCap":1772127},{"date":"2025-07-18","current":-0.071968,"twenty":-0.131041,"median":-0.093045,"eighty":-0.073765,"marketCap":1792225},{"date":"2025-07-25","current":-0.063351,"twenty":-0.128588,"median":-0.090543,"eighty":-0.073296,"marketCap":1577623},{"date":"2025-08-01","current":-0.067842,"twenty":-0.126702,"median":-0.088634,"eighty":-0.071968,"marketCap":1689455},{"date":"2025-08-08","current":-0.067469,"twenty":-0.125999,"median":-0.086782,"eighty":-0.070078,"marketCap":1680172},{"date":"2025-08-15","current":-0.065232,"twenty":-0.123231,"median":-0.082475,"eighty":-0.067842,"marketCap":1624476},{"date":"2025-08-22","current":-0.163949,"twenty":-0.128588,"median":-0.085165,"eighty":-0.067842,"marketCap":4581166},{"date":"2025-08-29","current":-0.148569,"twenty":-0.139807,"median":-0.088186,"eighty":-0.068463,"marketCap":4151409},{"date":"2025-09-05","current":-0.131706,"twenty":-0.144417,"median":-0.089502,"eighty":-0.068562,"marketCap":3680203},{"date":"2025-09-12","current":-0.159265,"twenty":-0.145746,"median":-0.092857,"eighty":-0.06939,"marketCap":4450276},{"date":"2025-09-19","current":-0.136062,"twenty":-0.147033,"median":-0.094578,"eighty":-0.069981,"marketCap":3801932},{"date":"2025-09-26","current":-0.133939,"twenty":-0.146021,"median":-0.100089,"eighty":-0.070244,"marketCap":3742595},{"date":"2025-10-03","current":-0.130675,"twenty":-0.145746,"median":-0.106501,"eighty":-0.070979,"marketCap":3651408},{"date":"2025-10-10","current":-0.125991,"twenty":-0.145314,"median":-0.109346,"eighty":-0.071159,"marketCap":3520517},{"date":"2025-10-17","current":-0.218599,"twenty":-0.145314,"median":-0.114136,"eighty":-0.071807,"marketCap":6108222},{"date":"2025-10-24","current":-0.100805,"twenty":-0.14503,"median":-0.113685,"eighty":-0.072126,"marketCap":2816763},{"date":"2025-10-31","current":-0.071997,"twenty":-0.144417,"median":-0.107803,"eighty":-0.072132,"marketCap":2011786},{"date":"2025-11-07","current":-0.099629,"twenty":-0.142772,"median":-0.105874,"eighty":-0.072945,"marketCap":2783885},{"date":"2025-11-14","current":-0.100434,"twenty":-0.140325,"median":-0.106691,"eighty":-0.073265,"marketCap":2806381},{"date":"2025-11-21","current":-0.060228,"twenty":-0.138735,"median":-0.104439,"eighty":-0.072945,"marketCap":1744006},{"date":"2025-11-28","current":-0.146631,"twenty":-0.143148,"median":-0.106255,"eighty":-0.073234,"marketCap":4245934},{"date":"2025-12-05","current":-0.107116,"twenty":-0.143148,"median":-0.106686,"eighty":-0.073577,"marketCap":3101707},{"date":"2025-12-12","current":-0.0934,"twenty":-0.140843,"median":-0.104503,"eighty":-0.073765,"marketCap":2704537},{"date":"2025-12-19","current":-0.076872,"twenty":-0.139003,"median":-0.100695,"eighty":-0.074234,"marketCap":2225953},{"date":"2025-12-26","current":-0.072042,"twenty":-0.13813,"median":-0.100262,"eighty":-0.073484,"marketCap":2086085},{"date":"2026-01-02","current":-0.062035,"twenty":-0.137543,"median":-0.09978,"eighty":-0.072263,"marketCap":1796325},{"date":"2026-01-09","current":-0.074333,"twenty":-0.137045,"median":-0.098089,"eighty":-0.07275,"marketCap":2152439}],"updateTime":1768252471724},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602158003","title":"Beta Drugs to Acquire Majority Stake in IVF-Focused Nivian Lifesciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2602158003","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602158003?lang=en_us&edition=fundamental","pubTime":"2026-01-10 23:14","pubTimestamp":1768058073,"startTime":"0","endTime":"0","summary":"Beta Drugs Ltd. ( ($IN:BETA) ) has issued an announcement. Beta Drugs Limited has signed a definitive agreement to acquire a 66.09% stake in Nivian...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beta-drugs-to-acquire-majority-stake-in-ivf-focused-nivian-lifesciences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beta-drugs-to-acquire-majority-stake-in-ivf-focused-nivian-lifesciences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BETA","IVF","BK4187"],"gpt_icon":0},{"id":"2601480878","title":"INVO Fertility Appoints Terah Krigsvold as CFO and Andrea Goren as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601480878","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601480878?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:06","pubTimestamp":1767733597,"startTime":"0","endTime":"0","summary":"INVO Fertility Inc. announced changes to its executive leadership team. Terah Krigsvold, previously the company's controller, has been appointed chief financial officer, replacing Andrea Goren. Andrea Goren will now serve as chief business officer and chief executive officer of INVO Centers LLC, a subsidiary focused on fertility clinics. The restructuring aims to support the company's growth strategy centered on acquiring and establishing fertility clinics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL8Sd6b7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"1195203883","title":"Jin Xin Reproductive (01951) Reports IVF Egg Retrieval Cycle Decline Narrows to -1.4% in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1195203883","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195203883?lang=en_us&edition=fundamental","pubTime":"2026-01-06 06:26","pubTimestamp":1767651987,"startTime":"0","endTime":"0","summary":"Jin Xin Reproductive (01951) announced that through continuous optimization of operational measures, its in-vitro fertilization (IVF) egg retrieval cycle numbers saw further improvement in the fourth...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK1597","IVF","01951","BK1583","BK1219"],"gpt_icon":0},{"id":"2595481037","title":"BRIEF-Terah Krigsvold Appointed As INVO's New CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2595481037","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595481037?lang=en_us&edition=fundamental","pubTime":"2025-12-31 06:35","pubTimestamp":1767134140,"startTime":"0","endTime":"0","summary":"BRIEF-Terah Krigsvold Appointed As INVO's New CFODec 30 (Reuters) - INVO Fertility Inc IVF.O:INVO FERTILITY INC - TERAH KRIGSVOLD APPOINTED AS INVO'S NEW CFOSource text: ID:nGNX1cwvcgFurther company coverage: IVF.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2595717281","title":"INVO Fertility Inc - Terah Krigsvold Appointed as INVO's New CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2595717281","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595717281?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:13","pubTimestamp":1767129202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","IVF"],"gpt_icon":0},{"id":"2595167717","title":"INVO Fertility Appoints Terah Krigsvold as CFO and Andrea Goren as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2595167717","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595167717?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:05","pubTimestamp":1767128724,"startTime":"0","endTime":"0","summary":"INVO Fertility Inc. has announced changes to its executive leadership team. Terah Krigsvold, previously the company’s controller, has been appointed chief financial officer, replacing Andrea Goren. Andrea Goren will now serve as chief business officer and chief executive officer of INVO Centers LLC, a wholly owned subsidiary focused on fertility clinics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via GlobeNewswire  on December 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDLbp73XG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4082","LU0314104364.USD","BK4112","IVF","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014013.SGD","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","NDAQ","SG9999014039.USD","BK4588"],"gpt_icon":0},{"id":"2595717163","title":"Press Release: INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2595717163","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595717163?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:05","pubTimestamp":1767128700,"startTime":"0","endTime":"0","summary":"SARASOTA, Fla., Dec. 30, 2025  -- INVO Fertility, Inc.  , a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced changes to its executive leadership team to align its human resources with the Company's growth strategy focused on the acquisition and establishment of fertility clinics and ancillary organizations.We are a healthcare services fertility company dedicated to expanding access to assisted reproductive technology  care to patients in need. Our principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including \"INVO Centers\" dedicated primarily to offering the intravaginal culture  procedure enabled by our INVOcell medical device  and US-based, profitable in vitro fertilization  clinics. We have two operational INVO Centers in the United States and one IVF clinic. We also continue to engage in the sale and distribution of INVOcel","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4022","BK4082","BK4232","IVF"],"gpt_icon":0},{"id":"2593446116","title":"Monash IVF Group Says Consortium Withdraws Takeover Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2593446116","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593446116?lang=en_us&edition=fundamental","pubTime":"2025-12-24 06:47","pubTimestamp":1766530035,"startTime":"0","endTime":"0","summary":"Monash IVF Group  said a consortium consisting of Genesis Capital Investment Management and WHSP Holdings  withdrew its non-binding indicative offer to acquire the company's shares for AU$0.80 apiece via a scheme of arrangement, according to a Wednesday filing with the Australian bourse.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1670710661.SGD","BK7113","BK4504","BK4082","BK7508","LU1670711040.USD","VFC","BK7105","BK7083","IVF","SOL.AU","BK4202","BK4585","BK4588","MVF.AU","LU1670710588.SGD","LU1670711123.USD"],"gpt_icon":0},{"id":"2592591345","title":"INVO Fertility Signs Definitive Agreement to Acquire Family Beginnings Clinic","url":"https://stock-news.laohu8.com/highlight/detail?id=2592591345","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592591345?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:01","pubTimestamp":1765980060,"startTime":"0","endTime":"0","summary":"INVO Fertility has signed a definitive agreement to acquire the non-clinical assets of Family Beginnings, a well-established fertility clinic serving Indiana and the Midwest. The purchase price totals $750,000, with $350,000 to be paid in cash at closing—subject to a $150,000 holdback—and $400,000 in Series D Non-Voting Convertible Preferred Stock. The transaction is expected to close by February 27, 2026. Family Beginnings, led by Dr. James Donahue, generated approximately $1.2 million in revenue and $0.2 million in net income over the trailing 12 months ended September 30, 2025. Dr. Donahue will continue to lead the clinic following the acquisition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the orig","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL1WpWhb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","LU2095319765.USD","BK4585","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4082","LU0314104364.USD","IVF","LU2210149790.SGD","IE00B3QW5Z07.USD","NDAQ","SG9999014005.SGD"],"gpt_icon":0},{"id":"2592131479","title":"INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”","url":"https://stock-news.laohu8.com/highlight/detail?id=2592131479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592131479?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:00","pubTimestamp":1765980001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA7NDW5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2590434123","title":"Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2590434123","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590434123?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:30","pubTimestamp":1765287000,"startTime":"0","endTime":"0","summary":"SINGAPORE, Dec.  09, 2025  (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/09/3202369/0/en/Cuprina-Holdings-Cayman-Limited-Announces-Financial-Results-for-the-Six-Months-Ended-June-30-2025-and-Strategic-Initiatives-for-2026-Growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211326755.USD","LU1023059063.AUD","LU1989764664.SGD","BK4126","LU2089284900.SGD","LU1989771016.USD","LU2089283258.USD","LU2271345857.HKD","LU1116320901.HKD","BK4172","IE000M9KFDE8.USD","BK4588","LU0265550946.USD","IVF","CUPR","BK4082","GEF","LU0122379950.USD","LU2089984988.USD","LU1291159041.SGD","LU0976567544.SGD","LU0211331839.USD","LU2111349929.HKD","LU0158827781.USD","LU0432979614.USD","BK4566","LU1116320737.USD","IE00BFXG1179.USD","IE00B1B80R65.USD","LU1244550221.USD","LU1983299246.USD","LU0496365809.HKD","LU2468319806.SGD","LU2023251221.USD","LU0072461881.USD","LU0211326839.USD","LU1244550577.SGD","LU1057294990.SGD","LU0320765489.SGD","LU1571399168.USD","LU0158827948.USD","SBS","LU0314106906.USD","LU1506573853.SGD","LU0265550359.USD","IE00BQXX3F31.USD","LU2028103732.USD","MDT","LU2112291526.USD","LU1989764748.USD"],"gpt_icon":0},{"id":"2590369237","title":"INVO Fertility Inc. Announces Date for Upcoming Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2590369237","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590369237?lang=en_us&edition=fundamental","pubTime":"2025-12-09 06:22","pubTimestamp":1765232542,"startTime":"0","endTime":"0","summary":"INVO Fertility Inc. has announced a special meeting of stockholders scheduled to take place virtually on January 22, 2026. During the meeting, stockholders will consider and vote on matters including an amendment to Article IV, Section  of the company's Articles of Amendment regarding the total number of authorized shares, and any other business that may properly come before the meeting or any adjournment thereof.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the informati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL3CWXg9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IVF"],"gpt_icon":0},{"id":"2589849065","title":"Director Matthew K. Szot Reports Disposal of Invo Fertility Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589849065","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589849065?lang=en_us&edition=fundamental","pubTime":"2025-12-06 10:41","pubTimestamp":1764988864,"startTime":"0","endTime":"0","summary":"Matthew K. Szot, Director of INVO Fertility, Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251206:nNDL90pzmb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Matthew K. Szot Reports Disposal of Invo Fertility Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2589853530","title":"Bid Target Monash IVF's Stock Trades Near Fair Value -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2589853530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589853530?lang=en_us&edition=fundamental","pubTime":"2025-12-05 06:57","pubTimestamp":1764889020,"startTime":"0","endTime":"0","summary":"2257 GMT - Macquarie says Monash IVF's share price appears close to fair value, as the in vitro fertilization specialist waits to see if Genesis Capital and Washington H. Soul Pattinson bid again. Monash IVF ended Thursday at A$0.865, above the consortium's A$0.80/share offer that was rejected. Monash IVF said the bid materially undervalues the company. However, Macquarie points out that while the consortium's offer is lower relative to past deals in the sector, the outlook for IVF has changed since 2022. \"Incidents have potentially weighed on customer acquisition and triggered greater regulatory scrutiny, likely increasing compliance costs as additional safeguards are implemented,\" Macquarie says. Aggressive competition from unlisted peers, especially in Victoria state, adds pressure. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","MVF.AU","SOL.AU","IVF","BK7083","BK7508","BK7113","BK7105"],"gpt_icon":0},{"id":"2588847022","title":"INVO Fertility Enacts 1-for-8 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2588847022","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588847022?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:47","pubTimestamp":1764798439,"startTime":"0","endTime":"0","summary":"Invo Fertility Inc. will implement a 1-for-8 reverse stock split effective at the opening of trading on November 28, 2025. Following the split, the company's common stock will continue to trade under the symbol \"IVF,\" and the new CUSIP number will be 44984F807. Approximately 1,891,151 shares of common stock will be outstanding after the split.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDLj4xs5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2588905928","title":"BRIEF-Invo Fertility Announces Pricing Of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2588905928","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588905928?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:25","pubTimestamp":1764685533,"startTime":"0","endTime":"0","summary":"BRIEF-Invo Fertility Announces Pricing Of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq RulesDec 2 (Reuters) - INVO Fertility Inc IVF.O:INVO FERTILITY ANNOUNCES PRICING OF $4.0 MILL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA1H25Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2588059496","title":"INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2588059496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588059496?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:25","pubTimestamp":1764685500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA1H25Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2588119727","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2588119727","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588119727?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:45","pubTimestamp":1764593159,"startTime":"0","endTime":"0","summary":"Q32 Bio  shares were 71% higher pre-bell Monday after the company said it has sold alopecia areata drug candidate ADX-097 to Akebia Therapeutics .Belite Bio  stock was up 17% after the company said that a late-stage trial of Tinlarebant to treat Stargardt eye disease met its primary efficacy endpoint.Canadian Solar  shares were 13% higher after the company said it will resume direct oversight of its US operations.INVO Fertility  stock was up 12% after the company said it plans to acquire fertility clinic Family Beginnings.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4141","QTTB","BK4588","BK4082","AKBA","BLTE","BK4526","BK4585","BK4139","BK4519","IVF","BK4007"],"gpt_icon":1},{"id":"2587731038","title":"INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”","url":"https://stock-news.laohu8.com/highlight/detail?id=2587731038","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587731038?lang=en_us&edition=fundamental","pubTime":"2025-11-29 02:05","pubTimestamp":1764353100,"startTime":"0","endTime":"0","summary":"Acquisition advances INVO’s national expansion strategy, enhances its clinical capabilities, and broadens access to innovative fertility care across the MidwestSARASOTA, Fla. and INDIANAPOLIS, Nov.  2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/28/3196438/0/en/INVO-Fertility-Announces-Intent-to-Acquire-Indiana-Based-Fertility-Clinic-Family-Beginnings.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2586429452","title":"INVO Fertility Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2586429452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586429452?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:50","pubTimestamp":1764204614,"startTime":"0","endTime":"0","summary":"19:50 EST INVO Fertility (IVF) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/invo-fertility-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/invo-fertility-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","IVF"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":86,"code":"91000000","status":"200"}]}}